by Joe Kunkle | Jul 18, 2022
Immunocore (IMCR) a standout chart in Biotech with shares flagging below $46 and higher by 31% while 600 August $50 calls bought at $2.90 to $3.50 on 7/18 with IV30 currently at 113.5%.
IMCR is a commercial-stage biotechnology company pioneeri...
Please login to continue reading this article.
Options Hawk Max
$300 | 30 days
More About this Plan
Options Hawk Elite
$149 | 30 days
